Listing 1 - 10 of 38 | << page >> |
Sort by
|
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Medicine --- Neurology & clinical neurophysiology --- Chronic pain --- neuropathic pain --- inflammatory pain --- visceral pain --- pain treatment --- analgesics --- Chronic pain --- neuropathic pain --- inflammatory pain --- visceral pain --- pain treatment --- analgesics
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Medicine --- Neurology & clinical neurophysiology --- Chronic pain --- neuropathic pain --- inflammatory pain --- visceral pain --- pain treatment --- analgesics
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Chronic pain --- neuropathic pain --- inflammatory pain --- visceral pain --- pain treatment --- analgesics
Choose an application
This text presents cutting-edge topics on and the diagnostic and therapeutic approaches for tear film abnormities, including dry eye disease and Meibomian gland dysfunction. A new management algorithm for Meibomian gland dysfunction, therapeutic eye drops and intense pulsed lasers for dry eye disease, and topical and systemic agents for neuropathic ocular pain are proposed in this issue.
Medicine --- cross-sectional study --- dry eye disease --- systemic comorbidity --- graves’ ophthalmopathy --- inflammation --- meibomian glands --- morphological changes --- meibomian gland dysfunction --- ocular surface disease --- dry eye symptoms --- questionnaire --- Bangladesh --- global health --- epidemiology --- aqueous-deficient dry eye --- meibomian gland --- intense pulsed light --- severe keratitis --- hyaluronan --- hylan A --- multicenter --- randomized trial --- gabapentin --- dry eye --- neuropathic pain --- diabetes --- neuropathic keratopathy --- neuropathy --- nerve growth --- neurotrophic --- Houttuynia --- ultrasonic atomization --- meibography --- meiboscore --- TRPM8 agonist --- cryosim-3 --- fatty acids --- vitamin D --- brief-type self-administered diet history questionnaire --- Japanese --- cross-sectional study --- dry eye disease --- systemic comorbidity --- graves’ ophthalmopathy --- inflammation --- meibomian glands --- morphological changes --- meibomian gland dysfunction --- ocular surface disease --- dry eye symptoms --- questionnaire --- Bangladesh --- global health --- epidemiology --- aqueous-deficient dry eye --- meibomian gland --- intense pulsed light --- severe keratitis --- hyaluronan --- hylan A --- multicenter --- randomized trial --- gabapentin --- dry eye --- neuropathic pain --- diabetes --- neuropathic keratopathy --- neuropathy --- nerve growth --- neurotrophic --- Houttuynia --- ultrasonic atomization --- meibography --- meiboscore --- TRPM8 agonist --- cryosim-3 --- fatty acids --- vitamin D --- brief-type self-administered diet history questionnaire --- Japanese
Choose an application
This text presents cutting-edge topics on and the diagnostic and therapeutic approaches for tear film abnormities, including dry eye disease and Meibomian gland dysfunction. A new management algorithm for Meibomian gland dysfunction, therapeutic eye drops and intense pulsed lasers for dry eye disease, and topical and systemic agents for neuropathic ocular pain are proposed in this issue.
Medicine --- cross-sectional study --- dry eye disease --- systemic comorbidity --- graves’ ophthalmopathy --- inflammation --- meibomian glands --- morphological changes --- meibomian gland dysfunction --- ocular surface disease --- dry eye symptoms --- questionnaire --- Bangladesh --- global health --- epidemiology --- aqueous-deficient dry eye --- meibomian gland --- intense pulsed light --- severe keratitis --- hyaluronan --- hylan A --- multicenter --- randomized trial --- gabapentin --- dry eye --- neuropathic pain --- diabetes --- neuropathic keratopathy --- neuropathy --- nerve growth --- neurotrophic --- Houttuynia --- ultrasonic atomization --- meibography --- meiboscore --- TRPM8 agonist --- cryosim-3 --- fatty acids --- vitamin D --- brief-type self-administered diet history questionnaire --- Japanese
Choose an application
This text presents cutting-edge topics on and the diagnostic and therapeutic approaches for tear film abnormities, including dry eye disease and Meibomian gland dysfunction. A new management algorithm for Meibomian gland dysfunction, therapeutic eye drops and intense pulsed lasers for dry eye disease, and topical and systemic agents for neuropathic ocular pain are proposed in this issue.
cross-sectional study --- dry eye disease --- systemic comorbidity --- graves’ ophthalmopathy --- inflammation --- meibomian glands --- morphological changes --- meibomian gland dysfunction --- ocular surface disease --- dry eye symptoms --- questionnaire --- Bangladesh --- global health --- epidemiology --- aqueous-deficient dry eye --- meibomian gland --- intense pulsed light --- severe keratitis --- hyaluronan --- hylan A --- multicenter --- randomized trial --- gabapentin --- dry eye --- neuropathic pain --- diabetes --- neuropathic keratopathy --- neuropathy --- nerve growth --- neurotrophic --- Houttuynia --- ultrasonic atomization --- meibography --- meiboscore --- TRPM8 agonist --- cryosim-3 --- fatty acids --- vitamin D --- brief-type self-administered diet history questionnaire --- Japanese
Choose an application
Arthritis --- Rheumatism --- Rheumatic Diseases --- periodicals. --- Arthritis. --- Rheumatic Diseases. --- Rhumatisme --- Arthrite --- Arthropathie neurogène --- Rheumatism. --- Rheumatic diseases --- Arthritides --- Joints --- Disease, Rheumatic --- Diseases, Rheumatic --- Rheumatic Disease --- Polyarthritis --- Polyarthritides --- Inflammation --- Collagen diseases --- Musculoskeletal system --- Rheumatology --- Diseases --- Charcot joints --- Arthrite. --- Rhumatisme. --- Charcot's joint --- Neuro-arthropathy --- Neurogenic arthropathy --- Neuropathic joint --- Charcot joints. --- Oligoarthritis --- Oligoarthritides
Choose an application
The Essential Charcot Neuroarthropathy: Biomechanics, Pathophysiology, and MRI Findings provides a comprehensive analysis of Charcot neuroarthropathy (or Charcot Foot) in diabetic patients. All aspects are covered, including epidemiology, biomechanics, pathophysiology, socioeconomic impacts, radiological findings, and differential diagnosis, with an emphasis on MRI. Chapters address the challenges of pre-and-post surgical management of Charcot neuroarthropathy and the role of unconventional imaging modalities in diagnosis. The book presents an analysis of the normal biomechanics of the ankle and foot, the biomechanical derangements of the ankle-foot unit (including abnormal gait) caused by diabetes Type II, and more. Finally, there is also a reference of the pathophysiology of diabetes-induced peripheral neuropathy and its direct link with the development of Charcot neuroarthropathy foot. Diabetes-induced Charcot foot is frequently misunderstood, misinterpreted and misdiagnosed which can lead to confusion and detrimental management with reported high morbidity.
Charcot joints. --- Diabetes --- Diabetic Foot --- Arthropathy, Neurogenic --- Complications. --- Charcot's Joint --- Arthropathies, Neurogenic --- Charcot Joint --- Charcots Joint --- Joint, Charcot's --- Neurogenic Arthropathies --- Neurogenic Arthropathy --- Diabetic Feet --- Foot Ulcer, Diabetic --- Feet, Diabetic --- Foot, Diabetic --- Charcot's joint --- Neuro-arthropathy --- Neurogenic arthropathy --- Neuropathic joint --- Joints --- Complications and sequelae --- Diseases --- Diabetes Complications
Choose an application
Cancer has been a patient-specific and difficult-to-treat disease for decades, resulting in more deaths since 1900 than all other diseases except cardiovascular diseases. As societies around the world continue to shift towards an aging population, the social and economic burden created by cancer will only rise in the coming decades, necessitating continued improvement in our cancer therapies. Remarkably, in the late 1800s, bone surgeon William Coley serendipitously discovered that bacteria could be administered to patients as an effective (and sometimes toxic) form of cancer therapy known as "Coley's Toxins". His discoveries unknowingly led to two fields of cancer therapy that have been in development for decades and are now leading to significant improvements in therapy for cancer patients: immune-based and toxin-based therapies for cancer. Articles included here discuss the discoveries that emerged from Coley's Toxins that enable us to harness the immune system and microbial toxins to combat cancers, as oncology shifts from a field dominated by chemotherapy for most of the 20th century to biologic therapies that will dominate the 21st century.
Medicine --- immunotoxin --- ribotoxin --- α-sarcin --- RNase T1 --- furin --- intracellular trafficking --- colorectal cancer --- botulinum toxin --- botulinum neurotoxin --- cancer --- cancer cells --- neuropathic pain --- post-surgical pain --- parotid gland --- submaxillary gland --- gustatory hyperhidrosis --- sialocele --- parotid fistula --- immunotherapy --- vaccine --- immune checkpoint inhibitors --- adoptive cell therapy --- cytokine therapy --- Coley's Toxins --- glioblastoma --- drug discovery --- cytotoxic necrotizing factor type 1 --- protein purification --- recombinant protein production --- shiga toxins --- Gb3/CD77 --- apoptosis --- ER stress --- autophagy --- Burkitt lymphoma --- immunotoxin --- ribotoxin --- α-sarcin --- RNase T1 --- furin --- intracellular trafficking --- colorectal cancer --- botulinum toxin --- botulinum neurotoxin --- cancer --- cancer cells --- neuropathic pain --- post-surgical pain --- parotid gland --- submaxillary gland --- gustatory hyperhidrosis --- sialocele --- parotid fistula --- immunotherapy --- vaccine --- immune checkpoint inhibitors --- adoptive cell therapy --- cytokine therapy --- Coley's Toxins --- glioblastoma --- drug discovery --- cytotoxic necrotizing factor type 1 --- protein purification --- recombinant protein production --- shiga toxins --- Gb3/CD77 --- apoptosis --- ER stress --- autophagy --- Burkitt lymphoma
Choose an application
Marine Drugs is glad to announce its first Special Issue book on “ion channels” related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue “Ion Channels as Marine Drug Targets”. Join us to explore the advanced research outcomes in this field: α-Conotoxin RgIA and a potent analog, RgIA4, in treatment of pain; botulinum toxin-chitosan nanoparticles in treatment of atrial fibrillation; 27-amino acid (aa)-long δ-conotoxin TxVIA that modulates mammalian CaV3.x; first venomics study of Conus tulipa venom; review on marine toxins targeting Kv1 channels; review on synthetic approaches to zetekitoxin AB; and review on marine natural products and drug resistance in latent tuberculosis. The second edition of this Special Issue is open for submissions, we look forward to your contribution.
Medicine --- conotoxin --- Conus tulipa --- intraspecific variation --- venomics --- transcriptomics --- proteomics --- conantokins --- net hunting strategy --- nirvana cabal --- ion channel modulators --- marine anti-TB compounds --- PZA --- MTB --- latent TB --- sponges --- nicotinic --- chemotherapy --- paclitaxel --- taxane --- neuropathic pain --- α9α10 --- saxitoxin --- zetekitoxin AB --- voltage-gated sodium channel --- guanidine alkaloid --- bioactives --- conotoxins 2 --- Kv1 --- marine toxins --- modulators --- potassium channels --- sea anemone toxins --- TxVIA --- mammalian NaV channel --- selective inhibitor --- T-type CaV3.2 --- botulinum toxin A1 --- chitosan nanoparticles --- antiarrhythmics --- pharmacological models of arrhythmia --- electrically induced arrhythmia --- conotoxin --- Conus tulipa --- intraspecific variation --- venomics --- transcriptomics --- proteomics --- conantokins --- net hunting strategy --- nirvana cabal --- ion channel modulators --- marine anti-TB compounds --- PZA --- MTB --- latent TB --- sponges --- nicotinic --- chemotherapy --- paclitaxel --- taxane --- neuropathic pain --- α9α10 --- saxitoxin --- zetekitoxin AB --- voltage-gated sodium channel --- guanidine alkaloid --- bioactives --- conotoxins 2 --- Kv1 --- marine toxins --- modulators --- potassium channels --- sea anemone toxins --- TxVIA --- mammalian NaV channel --- selective inhibitor --- T-type CaV3.2 --- botulinum toxin A1 --- chitosan nanoparticles --- antiarrhythmics --- pharmacological models of arrhythmia --- electrically induced arrhythmia
Listing 1 - 10 of 38 | << page >> |
Sort by
|